Singapore Institute of Advanced Medicine Holdings Ltd
Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist. The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am. Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases. SAM has strategic collaborations with public and private institutions for research and clinical work. SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi
Comments
I'm not sure about UE, but for our company we received quite a lot of jobs from semiconductor companies in the 4th quarter of 2010, we're currently carrying out these project and we'll probably receive more payments by mid year.
The market is mostly based on human nature after all, it always get better overtime. So I think it's quite good if we can get these shares while the price is still on the lower side.
I'll definitely try to get some offer shares.
Thanks for your blog by the way! I visit it regularly to check on updates.
The underwriters negotiated for $0.48 when STI was at about 3080 points (Feb 11 to Feb 18).
Current the STI is at 3158 points (Apr 5, 12:23) and UE E&C Ltd is only trading at $0.46